REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $680,374 | +0.4% | 24,580 | -3.0% | 0.00% | – |
| Q2 2023 | $677,578 | +38.7% | 25,330 | +12.3% | 0.00% | – |
| Q1 2023 | $488,585 | +9.3% | 22,557 | +20.2% | 0.00% | – |
| Q4 2022 | $447,126 | +35.9% | 18,771 | +12.6% | 0.00% | – |
| Q3 2022 | $329,000 | +34.3% | 16,672 | +32.4% | 0.00% | – |
| Q2 2022 | $245,000 | +15.0% | 12,590 | +51.0% | 0.00% | – |
| Q1 2022 | $213,000 | -4.1% | 8,335 | -5.3% | 0.00% | – |
| Q4 2021 | $222,000 | -43.7% | 8,805 | -38.6% | 0.00% | – |
| Q3 2021 | $394,000 | -48.0% | 14,339 | -40.0% | 0.00% | – |
| Q2 2021 | $758,000 | -30.5% | 23,889 | +0.5% | 0.00% | -100.0% |
| Q1 2021 | $1,090,000 | +17.7% | 23,761 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $926,000 | +356.2% | 23,387 | +301.7% | 0.00% | – |
| Q3 2020 | $203,000 | – | 5,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $175,333,000 | 30.61% |
| TRV GP IV, LLC | 1,419,900 | $45,068,000 | 21.46% |
| Ponoi II Management, LLC | 685,011 | $21,742,000 | 17.62% |
| Column Group LLC | 3,347,245 | $106,242,000 | 15.04% |
| Ponoi Management, LLC | 685,011 | $21,742,000 | 12.08% |
| Boxer Capital, LLC | 3,484,264 | $110,591,000 | 3.90% |
| Cormorant Asset Management, LP | 3,338,166 | $105,953,000 | 3.60% |
| BVF INC/IL | 2,485,049 | $78,875,000 | 2.96% |
| Casdin Capital, LLC | 2,305,000 | $73,161,000 | 1.86% |
| Burrage Capital Management LLC | 50,000 | $1,587,000 | 1.59% |